AngioDynamics sees Q4 net sales at lower end of prior view

June 6 (Reuters) - Medical device maker AngioDynamics Inc. (ANGO.O) now sees fourth-quarter net sales towards the lower end of its previous forecast.

The company now expects net sales of $40.5 million to $40.8 million in the quarter. In March, it had forecast revenue of about $40 million to $43 million.

Analysts on average expected the company to post revenue of $40.7 million, according to Reuters Estimates.

(Reporting by Bhaswati Mukhopadhyay in Bangalore)

((Editing by Amitha Rajan; Reuters Messaging:bhaswati.mukho.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: ANGIODYNAMICS OUTLOOK/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3264